Green leaves in a row with varied degrees of black spots on a black background.
A New Drug Fixes a Leak Caused by Bacteria
Kamal Nahas, PhD | Nov 8, 2023 | 5 min read
Researchers discovered how virulent bacterial proteins leech nutrients from plant cells, leading to a potential treatment for diseased crops.
Black and gold sketch of Katalin Karikó and Drew Weissman.
Nobel Prize for mRNA Vaccines
Danielle Gerhard, PhD | Oct 2, 2023 | 5 min read
Katalin Karikó and Drew Weissman received this year’s Physiology or Medicine award for their work on RNA biology and mRNA-based vaccines.
3D rendered microscopic view of neurons and synapses.
Blood-Based Biomarkers: New Outlooks for Neurological Disorders 
Quanterix | 1 min read
Ultra-sensitive biomarkers and immunoassays help researchers investigate neurological health and disease, leading to new therapeutics and diagnostics.
Matthew Disney
A Quest to Drug RNA
Ida Emilie Steinmark, PhD | Sep 8, 2023 | 5 min read
Matthew Disney’s idea of small molecules that target RNA once seemed fanciful. Now, even the pharma industry is pursuing it
<em>The Scientist</em> poster&nbsp;
New Strategies for Repurposing Existing Therapies 
The Scientist’s Creative Services Team | Aug 10, 2023 | 1 min read
Drug repurposing uses existing drugs beyond the scope in which they were originally approved by the Food and Drug Administration.
Advancing Drug Discovery by Employing Synthetic Biology Tools
Advancing Drug Discovery by Employing Synthetic Biology Tools
The Scientist’s Creative Services Team | 1 min read
In this webinar, learn about the origins of artificial gene circuits and how researchers currently use synthetic biology strategies to uncover new drugs. 
ConPlex predicts what proteins a drug is likely to bind, which can help identify new targets for existing drugs.
Simplifying the Search for Drug Targets
Aparna Nathan, PhD | Aug 1, 2023 | 3 min read
A new machine learning model promises fast prediction of drug-target interactions.
Microscopy image of a fluorescent green oligodendrocyte surrounded by astrocytes stained red with blue nuclei.
Searching for a Direct Route to Multiple Sclerosis Treatment
Deanna MacNeil, PhD | Jul 17, 2023 | 3 min read
Researchers created a new high-throughput tool to hunt for therapies that remyelinate the nervous system.
3D rendered illustration of the human gastrointestinal tract with an inset close up of the epithelium.
Exploring Preclinical Models for Inflammatory Bowel Disease
The Scientist’s Creative Services Team and Altis Biosystems | 4 min read
Learn how epithelial monolayer models help researchers discover effective therapies and biomarkers for inflammatory bowel diseases.
Histological stain of in blue, red, and green of tumor
Self-Charging Battery Battles Tumors in Mice
Natalia Mesa, PhD | Apr 4, 2023 | 3 min read
A battery that charges itself in salty fluids starves tumors of oxygen, helping improve some drugs treat cancer, a study finds.
Discover a new way to analyze tissue samples
Diving Deeper into Tissue Samples with Spatial Context
Canopy Biosciences | Mar 15, 2023 | 1 min read
Scientists developed a standardized multiplex immunohistochemistry and RNA in situ hybridization protocol using ChipCytometryTM.
Accelerating Antibody Discovery for Difficult Targets
Accelerating Antibody Discovery for Difficult Targets
The Scientist’s Creative Services Team | 1 min read
François Romagné will discuss how RNA immunization and single cell screening enhance antibody generation for poorly immunogenic proteins.
A cross-section of mouse brain showing the locus coeruleus in fluorescent green
Hormone Sobers Up Drunken Mice: Study
Alejandra Manjarrez, PhD | Mar 8, 2023 | 3 min read
A hormone naturally induced by alcohol consumption accelerates the recovery of mice after binge drinking by activating neurons involved in arousal and alertness.
Nerve cell labelled with different colours
Psychedelics Slip Past Cell Membranes When Treating Depression
Alejandra Manjarrez, PhD | Feb 24, 2023 | 4 min read
The antidepressant properties of hallucinogenic drugs may stem from their ability to bind to intracellular serotonin receptors, a study suggests.
Sino Biological&nbsp;
Introducing GMP-Grade Recombinant Cytokines for Stem Cell Research
The Scientist’s Creative Services Team and Sino Biological | 3 min read
Cutting edge technology delivers cytokines with high purity, high bioactivity, high batch-to-batch consistency, and high stability.
Dead shark on concrete
Researchers Make Alternatives to Shark-Sourced Vaccine Ingredient
Natalia Mesa, PhD | Feb 22, 2023 | 3 min read
Synthetic variations of squalene, which is used to boost immune responses, could make vaccines more effective while reducing fisheries for struggling sharks.
RSV vaccine design concept art
RSV Vaccines That Work?
Rachael Moeller Gorman | Feb 16, 2023 | 10+ min read
Multiple candidates are in Phase 3 clinical trials for older adults and pregnant women, with some getting close to approval in the United States.
Affinity versus Avidity: Differentiating Between Binding Phenomena &nbsp;
Affinity versus Avidity: Differentiating Between Binding Phenomena  
The Scientist’s Creative Services Team | 1 min read
In this webinar, Tim Heiseler will discuss the importance of assay design when measuring binding kinetics and affinity values, as well as strategies to mitigate avidity effects.
A mother mouse breastfeeds her offspring
Fast-Acting Nonhormonal Male Birth Control Prevents Pregnancy in Mice
Katherine Irving | Feb 15, 2023 | 5 min read
The “on demand” drug immobilizes sperm rather than limit their production, preventing 100 percent of pregnancies in an experiment.
A 3D medical illustration of a human heart with a cardiogram in the foreground and a blue background that includes DNA helices.
Connecting the Complexities of Heart Failure and Aging
Deanna MacNeil, PhD | Feb 13, 2023 | 3 min read
Researchers learned how IGFBP7, a senescence signaling protein and biomarker, promotes cardiac remodeling and cellular aging.